Adamed Pharma S.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Adamed Pharma S.A. - overview
Established
1986
Location
-, -, Poland
Primary Industry
Biotechnology
About
Founded in 1986 and based in Czosnów, Poland, Adamed Pharma S. A. , also known as Adamed Group, is a biotechnology company that manufactures over 350 products worldwide. The firm invested has invested 225 million euros in research and development and holds 94 pharmaceutical patents.
In 2021, the firm invested in Telemedicin sp. z o. o. series A funding.
Adamed Group produces medications that focus on 14 therapeutic areas such as allergology and pulmonology, angiology, antibiotics treatment, diabetology, gastroenterology, gynaecology, cardiology, painkillers, neurology, ophthalmology, dementia medication, psychiatry, rheumatology and urology. The firm's platform also features a drug prescription and its application.
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Medical Supplies, Pharmaceutical Research & Development, Medical Software
Website
www.adamed.com
Verticals
HealthTech, Manufacturing
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.